252 related articles for article (PubMed ID: 12125970)
1. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.
Nakamizo A; Inamura T; Ikezaki K; Yoshimoto K; Inoha S; Mizoguchi M; Amano T; Fukui M
J Neurooncol; 2002 Apr; 57(2):105-14. PubMed ID: 12125970
[TBL] [Abstract][Full Text] [Related]
2. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
[TBL] [Abstract][Full Text] [Related]
3. Cellular proliferation in pilocytic and diffuse astrocytomas.
Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
[TBL] [Abstract][Full Text] [Related]
4. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas.
Patt S; Gries H; Giraldo M; Cervos-Navarro J; Martin H; Jänisch W; Brockmöller J
Hum Pathol; 1996 Jun; 27(6):586-9. PubMed ID: 8666369
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
6. Mutations and immunohistochemistry of p53 and proliferation markers in astrocytic tumors of childhood.
Schiffer D; Cavalla P; Di Sapio A; Giordana MT; Mauro A
Childs Nerv Syst; 1995 Sep; 11(9):517-22. PubMed ID: 8529218
[TBL] [Abstract][Full Text] [Related]
7. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study.
Klein R; Roggendorf W
Acta Neuropathol; 2001 Mar; 101(3):245-8. PubMed ID: 11307624
[TBL] [Abstract][Full Text] [Related]
8. Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas.
Tihan T; Davis R; Elowitz E; DiCostanzo D; Moll U
Arch Pathol Lab Med; 2000 Jan; 124(1):108-13. PubMed ID: 10629140
[TBL] [Abstract][Full Text] [Related]
9. The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up.
Dirven CM; Koudstaal J; Mooij JJ; Molenaar WM
J Neurooncol; 1998 Mar; 37(1):9-16. PubMed ID: 9525833
[TBL] [Abstract][Full Text] [Related]
10. Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis.
Cummings TJ; Provenzale JM; Hunter SB; Friedman AH; Klintworth GK; Bigner SH; McLendon RE
Acta Neuropathol; 2000 May; 99(5):563-70. PubMed ID: 10805102
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas.
Haapasalo H; Sallinen S; Sallinen P; Helén P; Jääskeläinen J; Salmi TT; Paetau A; Paljärvi L; Visakorpi T; Kalimo H
Neuropathol Appl Neurobiol; 1999 Apr; 25(2):134-42. PubMed ID: 10216001
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors.
Khalid H; Shibata S; Kishikawa M; Yasunaga A; Iseki M; Hiura T
Cancer; 1997 Dec; 80(11):2133-40. PubMed ID: 9392336
[TBL] [Abstract][Full Text] [Related]
13. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
14. Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.
Kim CH; Bak KH; Kim YS; Kim JM; Ko Y; Oh SJ; Kim KM; Hong EK
Surg Neurol; 2000 Sep; 54(3):235-40. PubMed ID: 11118570
[TBL] [Abstract][Full Text] [Related]
15. CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.
Miettinen H; Kononen J; Sallinen P; Alho H; Helen P; Helin H; Kalimo H; Paljärvi L; Isola J; Haapasalo H
J Neurooncol; 1999 Feb; 41(3):205-11. PubMed ID: 10359140
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
Machen SK; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
[TBL] [Abstract][Full Text] [Related]
17. Peroxiredoxins and antioxidant enzymes in pilocytic astrocytomas.
Nordfors K; Haapasalo J; Helén P; Paetau A; Paljärvi L; Kalimo H; Kinnula VL; Soini Y; Haapasalo H
Clin Neuropathol; 2007; 26(5):210-8. PubMed ID: 17907597
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins.
Ellison DW; Steart PV; Gatter KC; Weller RO
Neuropathol Appl Neurobiol; 1995 Aug; 21(4):352-61. PubMed ID: 7494604
[TBL] [Abstract][Full Text] [Related]
20. Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay.
Ishii N; Sawamura Y; Tada M; Daub DM; Janzer RC; Meagher-Villemure M; de Tribolet N; Van Meir EG
Int J Cancer; 1998 Jun; 76(6):797-800. PubMed ID: 9626343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]